140 related articles for article (PubMed ID: 1619004)
1. Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature.
Rosenbaum M; Gertner JM; Gidfar N; Hirsch J; Leibel RL
J Clin Endocrinol Metab; 1992 Jul; 75(1):151-6. PubMed ID: 1619004
[TBL] [Abstract][Full Text] [Related]
2. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children.
Rosenbaum M; Gertner JM; Leibel RL
J Clin Endocrinol Metab; 1989 Dec; 69(6):1274-81. PubMed ID: 2685009
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in adrenoreceptor status of adipose tissue in adults and prepubertal children.
Rosenbaum M; Presta E; Hirsch J; Leibel RL
J Clin Endocrinol Metab; 1991 Aug; 73(2):341-7. PubMed ID: 1649839
[TBL] [Abstract][Full Text] [Related]
4. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal.
Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin.
Ibáñez L; Lopez-Bermejo A; Díaz M; Jaramillo A; Marín S; de Zegher F
J Clin Endocrinol Metab; 2010 May; 95(5):2234-9. PubMed ID: 20332245
[TBL] [Abstract][Full Text] [Related]
6. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency.
Sas T; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539
[TBL] [Abstract][Full Text] [Related]
7. Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein.
Balaž M; Ukropcova B; Kurdiova T; Vlcek M; Surova M; Krumpolec P; Vanuga P; Gašperíková D; Klimeš I; Payer J; Wolfrum C; Ukropec J
Adipocyte; 2015; 4(2):113-22. PubMed ID: 26167410
[TBL] [Abstract][Full Text] [Related]
8. Site- and sex-related differences in adrenoreceptor status of human adipose tissue.
Leibel RL; Hirsch J
J Clin Endocrinol Metab; 1987 Jun; 64(6):1205-10. PubMed ID: 3571424
[TBL] [Abstract][Full Text] [Related]
9. Abdominal vs buttock adipose fat: relationships with children's serum lipid levels.
Mamalakis G; Kafatos A; Manios Y; Kalogeropoulos N; Andrikopoulos N
Eur J Clin Nutr; 2002 Nov; 56(11):1081-6. PubMed ID: 12428173
[TBL] [Abstract][Full Text] [Related]
10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
11. High-dose growth hormone treatment of short children born small for gestational age.
de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG
J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853
[TBL] [Abstract][Full Text] [Related]
12. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy.
Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD
Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714
[TBL] [Abstract][Full Text] [Related]
13. Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue.
Rosenbaum M; Malbon CC; Hirsch J; Leibel RL
J Clin Endocrinol Metab; 1993 Aug; 77(2):352-5. PubMed ID: 8393882
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback.
Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G
J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism.
Hannon TS; Danadian K; Suprasongsin C; Arslanian SA
J Clin Endocrinol Metab; 2007 Aug; 92(8):3033-9. PubMed ID: 17519313
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism.
Rydén M; Arner P
J Intern Med; 2017 Sep; 282(3):220-228. PubMed ID: 28635127
[TBL] [Abstract][Full Text] [Related]
17. The regulation of adipose tissue distribution in humans.
Björntorp P
Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455
[TBL] [Abstract][Full Text] [Related]
18. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
Pasquino AM; Pucarelli I; Roggini M; Segni M
J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
[TBL] [Abstract][Full Text] [Related]
19. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy.
Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J
J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880
[TBL] [Abstract][Full Text] [Related]
20. Lipid patterns in treated growth hormone deficient children vs. short stature controls.
Foster C; Burton A; Scholl J; Scott ML; Gunter V; McCormick K
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):909-14. PubMed ID: 24859507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
